Invea Therapeutics
Aman Kant has a Bachelor of Technology in Biotechnology from Jaypee University of Information Technology. Currently, Aman is the Chief Business Officer and Founding Member at Invea Therapeutics since November 2021 and InveniAI since April 2017. Prior to this, Aman held various positions at BioXcel Corporation from June 2006 to April 2017, ranging from Manager to Vice President in Business Development and Alliances.
Invea Therapeutics
1 followers
Invea Therapeutics focuses on the discovery of transformational therapeutics for inflammatory gastrointestinal and hepatobiliary disorders.